Chen, Chen <br/><br/>
Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  08 2017 
 - 219-229 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.117.240986  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis--drug effects<br/>Carcinoma, Lewis Lung--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Nanog Homeobox Protein--antagonists & inhibitors<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Sorafenib<br/>Triazoles--administration & dosage<br/>Xenograft Model Antitumor Assays--methods